| 高雄醫學大學 |
2008 |
Changing Prevalence of Hepatitis C Virus Infection among Teenagers in an Endemic Area in Taiwan
|
黃釧峰;黃志富;戴嘉言;余明隆;盧勝男;謝明彥;李立柏;林子堯;陳信成;謝明裕;王良彥;張文宇;莊萬龍 |
| 高雄醫學大學 |
2008 |
C型肝炎感染增加代謝症候群之風險-高盛行區之社區研究
|
黃志富;余明隆;戴嘉言;謝明裕;黃釧峰;莊萬龍 |
| 高雄醫學大學 |
2007 |
干適能治療干安能抗藥性突變株B型肝炎病毒
|
戴嘉言;莊萬龍;謝明彥;李立柏;黃志富;侯乃仁;林子堯;陳信成;謝明裕;王良彥;蔡榮發;張文宇;余明隆 ; Dai CY;Chuang WL;Hsieh MY;Lee LP;Huang JF;Hou NJ;Lin ZY;Chen SC;Hsieh MY;Wang LY;Tsai JF;Chang WY;Yu ML |
| 高雄醫學大學 |
2007 |
在台灣慢性C型肝炎之肝臟脂肪變性及肝臟纖維化
|
謝孟軒;李立柏;謝明彥;蔡坤寶;黃志富;侯乃仁;陳信成;林子堯;謝明裕;王良彥;戴嘉言;莊萬龍;余明隆 ; Hsieh MH;Lee LP;Hsieh MY;Tsai KB;Huang JF;Hou NJ;Chen SC;Lin ZY;Hsieh MY;Wang LY;Dai CY;Chuang WL;Yu ML |
| 高雄醫學大學 |
2007 |
(在台灣慢性C型肝炎之肝臟脂肪變性及肝臟纖維化)
|
謝孟軒;李立柏;謝明彥;蔡坤寶;黃志富;侯乃仁;陳信成;林子堯;謝明裕;王良彥;戴嘉言;莊萬龍;余明隆 ; Hsieh MH;Lee LP;Hsieh MY;Tsai KB;Huang JF;Hou NJ;Chen SC;Lin ZY;Hsieh MY;Wang LY;Dai CY;Chuang WL;Yu ML |
| 高雄醫學大學 |
2007 |
在一B型與C型肝炎高盛行區C型肝炎病毒血症增加第二型糖尿病的相關性
|
黃志富;戴嘉言;黃尚志;何啟功;蕭璧容;謝明彥;李立柏;林子堯;陳信成;謝明裕;王良彥;辛錫璋;張文宇;莊萬龍; , 余明隆; Huang, JF;Dai, CY;Hwang, SJ;Ho, CK;Hsiao, PJ;Hsieh, MY;Lee, LP;Lin, ZY;Chen, SC;Hsieh, MY;Wang, LY;Shin, SJ;Chang, WY;Chuang, WL;ML , Yu |
| 高雄醫學大學 |
2007 |
Hepatitis C viremia increases risk of type 2 diabetes mellitus in a hepatitis B and C endemic area
|
黃志富;余明隆;莊萬隆;戴嘉言;何啟功;李立柏;謝明彥;林子堯;陳信成;謝明裕;辛錫璋;張文宇 |
| 高雄醫學大學 |
2007 |
The HBV Infection Among Aboriginal Children 20 Years After Immunization In Taiwan
|
莊萬龍;余明隆;戴嘉言;何啟功;黃釧峰;侯乃仁;李立柏;謝明彥;黃志富;林子堯;陳信成;謝明裕;王良彥;張文宇 |
| 高雄醫學大學 |
2007 |
干安能治療B型肝炎引起失償非肝硬化病患早期死亡率及反應-以MELD及INDEX指標評估
|
戴嘉言;余明隆;侯乃仁;謝明彥;李立柏;黃志富;林子堯;陳信成;謝明裕;王良彥;張文宇;莊萬龍 |
| 高雄醫學大學 |
2007 |
The antinuclear antibody is associated with lower RNA levels of hepatitis C virus and more advanced fibrosis in chronic hepatitis C patients
|
謝明彥;黃志富;侯乃仁;戴嘉言;李立柏;林子堯;陳信成;謝明裕;王良彥;張文宇;莊萬龍;余明隆 |
| 高雄醫學大學 |
2007 |
Almost all HCV G2 Pts With Rapid Virologic Response at Wk 4 Achieve a SVR With 16 Wks of Treatment
|
余明隆;戴嘉言;黃志富;侯乃仁;李立柏;謝明彥;丘長富;林子堯;陳信成;謝明裕;王良彥;張文宇;莊萬龍 |
| 高雄醫學大學 |
2007 |
Evaluation of the Abbott HCV RealTime PCR Assay for quantification of HCV viral loads
|
莊萬龍;黃志富;余明隆;戴嘉言;李立柏;謝明彥;林子堯;陳信成;謝明裕;張文宇 |
| 高雄醫學大學 |
2007 |
Different Features In Liver Histopathology Of HCV Monoinfection And HCV/HBV Dual Infection
|
李立柏;余明隆;戴嘉言;侯乃仁;謝明彥;林子堯;陳信成;謝明裕;王良彥;Chen, Tong-Jong;張文宇;莊萬龍 |
| 高雄醫學大學 |
2007 |
The Seroprevalence Of HBV And HCV Infection In Southern Taiwan- Large Scale Community-Based Study
|
莊萬龍;余明隆;戴嘉言;林嘉益;侯乃仁;李立柏;謝明彥;黃志富;謝明裕;張文宇 |
| 高雄醫學大學 |
2007 |
Transforming Growth Factor-Beta 1 Gene Polymorphisms In High Dose IFN/Ribavirin treated CHC Patients
|
戴嘉言;余明隆;張文宇;李立柏;潘文正;侯乃仁;謝明彥;黃志富;陳信成;林子堯;謝明裕;王良彥;莊萬龍 |
| 高雄醫學大學 |
2007 |
EARLY MORTALITY AND RESPONSES IN NON-CIRRHOTIC PATIENTS WITH CHRONIC HEPATITIS B-RELATED DECOMPENSATION WITH LAMIVUDINE THERAPY: EVALUATION OF MELD AND INDEX SCORING SYSTEMS AS PROGNOSTIC PREDICTORS
|
戴嘉言;余明隆;侯乃仁;謝明彥;李立柏;黃志富;林子堯;陳信成;謝明裕;王良彥;張文宇;莊萬龍 |
| 高雄醫學大學 |
2007 |
The presence of Antinuclear Antibody is associated with a negative response to combination therapy with peginterferon and ribavirin for patients without genotype 1 chronic hepatitis C infection
|
謝明彥;戴嘉言;黃志富;莊萬龍;侯乃仁;李立柏;陳信成;謝明裕;王良彥;張文宇;余明隆 |
| 高雄醫學大學 |
2007 |
High chance of cure in HCV genotype 1 patients with a low viral load achieving an RVR treated for 24 wks with pegylated interferon alfa-2a (PEGASYS) plus ribavirin (COPEGUS): Prospective, randomized, controlled study comparing 24 & 48 wks of treatm
|
余明隆;戴嘉言;黃志富;李立柏;謝明彥;丘長富;侯乃仁;林子堯;陳信成;謝明裕;王良彥;張文宇;莊萬龍* |
| 高雄醫學大學 |
2006 |
Discordant influence of amphotericin B on epirubicin cytotoxicity in primary hepatic malignant cells collected by a new primary culture technique.
|
林子堯;莊萬龍;莊豔凰;余明隆;謝明裕;王良彥;蔡榮發 ; Zu-Yau Lin;Wan-Long Chuang;Yen-Huang Chuang;Ming-Lung Yu;Ming-Yuh Hsieh;Liang-Yen Wang;Jung-Fa Tsai |
| 高雄醫學大學 |
2006 |
A randomized trial of 24- vs. 48-week courses of PEG interferon alpha-2b plus ribavirin for genotype-1b-infected chronic hepatitis C patients: a pilot study in Taiwan.
|
余明隆;戴嘉言;林子堯;李立柏;侯乃仁;謝明彥;陳信成;謝明裕;王良彥;張文宇;莊萬龍 ; Ming-Lung Yu;Chia-Yen Dai;Zu-Yau Lin;Li-Po Lee;Nei-Jen Hou;Ming-Yen Hsieh;Shinn-Cherng Chen;Ming-Yuh Hsieh;Liang-Yen Wang;Wen-Yu Chang;Wan-Long Chuang |
| 高雄醫學大學 |
2006 |
A simple noninvasive index for predicting long-term outcome of chronic hepatitis C after interferon-based therapy.
|
余明隆;林錫銘;李全謨;戴嘉言;張文宇;陳信成;李立柏;林子堯;謝明裕;王良彥;莊萬龍;廖運範 ; Yu ML;Lin SM;Lee CM;Dai CY;Chang WY;Chen SC;Lee LP;Lin ZY;Hsieh MY;Wang LY;Chuang WL;Liaw YF |
| 高雄醫學大學 |
2006 |
Outcome of chronic hepatitis C patients who required early termination of pegylated interferon-alpha plus ribavirin combination therapy.
|
余明隆;戴嘉言;李立柏;謝明彥;侯乃仁;黃志富;林子堯;陳信成;謝明裕;王良彥;張文宇;莊萬龍 ; Yu ML;Dai CY;Lee LP;Hsieh MY;Hou NJ;Huang JF;Lin ZY;Chen SC;Hsieh MY;Wang LY;Chang WY;Chuang WL |
| 高雄醫學大學 |
2006 |
The role of thyroid autoantibodies in the development of thyroid dysfunction in Taiwanese chronic hepatitis C patients with interferon-alpha and ribavirin combination therapy.
|
黃志富;莊萬龍;戴嘉言;陳信成;林子堯;李立柏;王良彥;謝明裕;張文宇;余明隆 ; Jee-Fu Huang;Wan-Long Chuang;Chia-Yen Dai;Shinn-Cherng Chen;Zu-Yau Lin;Li-Po Lee;Liang-Yen Wang;Ming-Yuh Hsieh;Wen-Yu Chang;Ming-Lung Yu |
| 高雄醫學大學 |
2006 |
Tumor necrosis factor- alpha promoter polymorphism at position -308 predicts response to combination therapy in hepatitis C virus infection.
|
戴嘉言;莊萬龍;張文宇;陳信成;李立柏;謝明彥;侯乃仁;林子堯;黃志富;謝明裕;王良彥;余明隆 ; Dai CY;Chuang WL;Chang WY;Chen SC;Lee LP;Hsieh MY;Hou NJ;Lin ZY;Huang JF;Hsieh MY;Wang LY;Yu ML |
| 高雄醫學大學 |
2006 |
A randomized study of peginterferon and ribavirin for 16 vs 24 weeks in patients with genotype 2 chronic hepatitis C
|
余明隆;戴嘉言;黃志富;侯乃仁;李立柏;謝明彥;丘長富;林子堯;陳信成;謝明裕;王良彥;張文宇;莊萬龍 |
